Publication Date

6-1-2016

Journal

The Texas Heart Journal

DOI

10.14503/THIJ-15-5080

PMID

27303241

Publication Date(s)

June 2016

Language

English

PMCID

PMC4894704

PubMedCentral® Posted Date

6-1-2016

PubMedCentral® Full Text Version

Post-Print

Published Open-Access

yes

Keywords

Arteriovenous shunt, surgical/methods; blood vessel prosthesis implantation/methods; cardiac catheterization/instrumentation; cyanosis/therapy; heart septal defects, atrial/therapy; percutaneous coronary intervention/instrumentation/methods; prosthesis design; pulmonary artery/surgery; septal occluder device; treatment outcome; ventricular function, right

Abstract

When total correction is not possible in infants who have a cyanotic congenital heart disease, creation of a palliative aortopulmonary shunt is essential. A central aortopulmonary shunt is preferable, because of its technical and hemodynamic advantages. Overcirculation, thrombosis, and stenosis of the shunt are the main postoperative sequelae that necessitate urgent reintervention. Percutaneous transcatheter closure of aortopulmonary shunts can eliminate the need for reoperation and substantially decrease postoperative morbidity and mortality rates. We report our successful transcatheter closures of central aortopulmonary shunts in a 3-month-old infant and a 15-year-old girl, with use of an Amplatzer Duct Occluder II and an Amplatzer Vascular Plug I, respectively. To our knowledge, this is the first report of the transcatheter closure of central aortopulmonary shunts with these 2 devices.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.